Defibrotide Has a Role in COVID-19 Therapy

Chest. 2022 Aug;162(2):271-273. doi: 10.1016/j.chest.2022.04.143.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • COVID-19*
  • Fibrinolytic Agents / therapeutic use
  • Humans
  • Polydeoxyribonucleotides

Substances

  • Fibrinolytic Agents
  • Polydeoxyribonucleotides
  • defibrotide